Le Lézard
Classified in: Health
Subject: FDA

US MEDICAL GLOVE (USMG) RECEIVES WORLD'S FIRST FDA 510(k) CLEARANCE FOR CHEMO-RATED PATIENT EXAM GLOVES PRODUCED USING ITS OWN MANUFACTURED AMERICAN-MADE MACHINES


MONTGOMERY, Ill.,  Jan. 18, 2023 /PRNewswire/ -- USMG is now in 24-hour production, selling and shipping daily cartons of both its patient examination gloves and its 6-mil industrial general purpose nitrile gloves across these United States.

US Medical glove is funded by Health and Human Services (HHS) and supports President Biden's Build Back America plan.

US Medical Glove receives FDA 510k Approval

www.usmg.us
[email protected]

SOURCE US Medical Glove


These press releases may also interest you

at 10:20
Sound Pharmaceuticals (SPI) is pleased to announce that it has received FDA notification that its Investigational New Drug Application (IND) may proceed involving SPI-1005 treatment and cochlear implantation (CI). The goal of this Phase 2 SPI-1005...

at 10:13
FDNA Inc, the leader in the early detection of rare genetic diseases, and Genome Medical, the nation's leading telehealth provider of genetic services, have partnered to empower parents to detect potential developmental, neurological and...

at 10:11
Most parents are used to hearing pediatricians discourage screen time for kids, but during National Safe Sun Week doctors are actually asking for more ? sunscreen time that is! Keeping skin protected by increasing summer "screen time" is a major...

at 10:02
SOPHiA GENETICS , a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that Instituto Mário Penna is live on the SOPHiA DDMtm Platform. Located in Belo Horizonte, Brazil, the Instituto Mário Penna...

at 10:01
Phenomix Sciences (Phenomix), a precision medicine biotechnology company that brings data intelligence to the treatment of obesity, announces the results of a groundbreaking independent study led by Mayo Clinic and presented at Digestive Disease Week...

at 10:00
Up to 18% of patients undergoing ACL reconstruction experience graft failure and require revision surgery, which is known to increase the risk of developing post-traumatic osteoarthritis (PTOA). A new trial led by the Center for Regenerative Medicine...



News published on and distributed by: